Exponent CHRO awarded 3,564 RSUs

Kundert Brian reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Kundert Brian reported acquisition or exercise transactions in this Form 4 filing.

Exponent Inc. reported that Chief Human Resources Officer Brian Kundert received a grant of 3,564 restricted stock units on March 13, 2026. These units represent a 1-for-1 right to receive shares of common stock, typically as part of long-term equity compensation.

Following this award, he is reported as holding 3,564 restricted stock units directly. The transaction is recorded as a grant or award, not an open-market purchase or sale, and therefore reflects standard executive compensation rather than a discretionary trade.

Insider Trade Summary

Grant/Award: 3,564 shares

Grant/Award 1 txn

Insider Kundert Brian

Role Chief Human Resources Officer

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	3,564	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 3,564 contracts (Direct)

Footnotes (2)

1. F1. 1-for-1.
2. F2. Not applicable.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Exponent (EXPO) disclose about Brian Kundert in this Form 4?

Exponent disclosed that Chief Human Resources Officer Brian Kundert received 3,564 restricted stock units on March 13, 2026. The filing classifies this as a grant or award, reflecting equity-based compensation rather than any open-market buying or selling of the company’s common stock.

How many restricted stock units did EXPO’s Brian Kundert receive?

Brian Kundert received 3,564 restricted stock units. Each unit represents a right to receive one share of Exponent common stock in the future, aligning his compensation with shareholder interests through equity rather than immediate cash or open-market stock transactions.

Was Brian Kundert’s Exponent (EXPO) transaction a purchase or sale of shares?

The transaction was neither an open-market purchase nor a sale. It was reported as a grant or award of 3,564 restricted stock units, meaning the company granted equity to Brian Kundert as part of his compensation, with no trading on the open market involved.

What is the significance of the 1-for-1 footnote in EXPO’s Form 4?

The 1-for-1 footnote indicates each restricted stock unit corresponds to one share of Exponent common stock. This clarifies that the 3,564 units granted to Brian Kundert can ultimately convert into 3,564 common shares, subject to the applicable vesting and settlement terms.

How many Exponent (EXPO) restricted stock units does Brian Kundert hold after this grant?

After the reported grant, Brian Kundert is shown as holding 3,564 restricted stock units directly. This total reflects the newly awarded units and represents his visible derivative equity position in the company as of the transaction reported in the Form 4.

Does this EXPO Form 4 show any remaining derivative positions for Brian Kundert?

The filing’s derivative summary is empty apart from this grant, indicating no additional derivative positions such as options are shown. The only derivative security reported is the 3,564 restricted stock units awarded on March 13, 2026, linked to Exponent common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/16/2026 - 04:18 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kundert Brian

(Last) (First) (Middle)

149 COMMONWEALTH DRIVE

(Street)

MENLO PARK CA 94025

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EXPONENT INC [ EXPO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Human Resources Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/13/2026		A		3,564		03/13/2030	03/13/2030	Common Stock	3,564	(2)	3,564	D

Explanation of Responses:

1. 1-for-1.

2. Not applicable.

	By: Wendy Whitehouse For: Brian Kundert	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.